Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000440 · ClinicalTrials.gov registry record · Phase 2
Sertraline and Naltrexone for Alcohol Dependence
A Phase 2 study, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- Completed
- Registry status
- Phase 2
- Development phase
- 124
- Enrollment target
NCT00000440 is a Phase 2 study that has completed, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 124 participants.
The verdict
NCT00000440, a Phase 2 study, has completed, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 124 participants
- Enrollment target
Study Summary
This study is a double-blind, placebo-controlled outpatient trial to improve, through the addition of sertraline (Zoloft), the abstinence and relapse rates in alcohol- dependent individuals currently taking naltrexone (Revia).
Interventions
- DRUG naltrexone (Revia)
- DRUG sertraline (Zoloft)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 124 participants |
| Est. Completion | 2002-09 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000440
The ClinicalTrials.gov registry entry for NCT00000440 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which naltrexone (Revia) is the first listed.
NCT00000440 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000440 about?
NCT00000440 is a clinical study titled "Sertraline and Naltrexone for Alcohol Dependence". This study is a double-blind, placebo-controlled outpatient trial to improve, through the addition of sertraline (Zoloft), the abstinence and relapse rates in alcohol- dependent individuals currently taking naltrexone (Revia).
What is the current status of trial NCT00000440?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 124 participants. Estimated completion is 2002-09.
What interventions are being tested in trial NCT00000440?
The interventions under investigation include: naltrexone (Revia) (DRUG), sertraline (Zoloft) (DRUG).
Who is sponsoring clinical trial NCT00000440?
This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.